BioCatalyst

Guselkumab Subcutaneous, Guselkumab Intravenous — catalyst calendar

1 verified catalyst event(s) referencing Guselkumab Subcutaneous, Guselkumab Intravenous, each linked to its official source. Verified as of 2026-10-11.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-02-10
in 4mo
ESTIMATED
 READOUT
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Acti
Phase 3 · Colitis, Ulcerative
 Janssen Research & Development, LL Guselkumab Subcutaneous, Guselkumab Intr ClinicalTrials.gov ↗
✓ Source-checked 2026-10-11
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.